The University of Oxford and the University of Sydney have shown, in a large study on the use of statins and its suspected relationship with cancer, that there is no evidence to suggest that taking stains to reduce cholesterol levels has any effects on the risk of suffering from cancer.
Over 26 different trials and out of a total of over 166,000 participants, 10,000 developed cancer of which 3,500 died as a result. The cancer rates were shown to be the same among those taking statins as those taking the placebo. The Cholesterol Treatments Trialists’ Collaboration analysed the data and found that there was no link between the two. Furthermore, there was no increased risk of developing specific cancers such as breast, prostate or bladder cancer or of certain groups developing cancer. The study also showed that increasing the dosage of the statin had no causal link with cancer; neither did statin consumption prevent the disease.
This is great news for those taking statins to improve their health and to reduce the risk of the possibility of developing heart disease or suffering from a stroke.